Why is Indo US Bio-Tech falling/rising?

As of 25-Jul, Indo US Bio-Tech Ltd's stock price is currently at 169.90, reflecting a slight increase of 0.05 (0.03%). The stock has shown a trend reversal by gaining after three consecutive days of decline. It is performing in line with its sector today, and the delivery volume has increased by 20.41% compared to the five-day average, indicating rising investor participation. Despite a year-to-date decline of 46.06%, the company has demonstrated strong operational growth, with a 107.86% increase in profit after tax and a 50.32% rise in net sales over the latest six months. However, the stock's valuation appears expensive, with a high enterprise value to capital employed ratio and a PEG ratio of 0.2, which may be contributing to investor caution.
Broader market context shows that while Indo US Bio-Tech has underperformed the market with a one-year return of -24.12% compared to the Sensex's gain of 1.78%, it has outperformed in the longer term, with a three-year return of +243.58% against the benchmark's +46.08%. The stock's recent performance contrasts with the broader market, which has seen a slight decline of -0.36% over the past week. This discrepancy highlights the challenges faced by Indo US Bio-Tech in regaining investor confidence despite its strong operational metrics and recent positive results.